News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GE Healthcare and Affibody to Collaborate on Her2 specific PET Imaging Agent for Breast and Gastric Cancer


6/7/2012 11:44:30 AM

CHALFONT ST GILES, England, & SOLNA, Sweden--(BUSINESS WIRE)--GE Healthcare (NYSE:GE) signed an agreement with Affibody AB (“Affibody”) to collaborate on the development of a Her2-targeted PET imaging agent, which is scheduled to begin clinical trials later this year.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES